Hikma acquires Novugen`s FDA-approved ANDA for trametinib
17 Apr 2025 //
PR NEWSWIRE
Novugen`s Generic Pazopanib Hydrochloride Receives Approval in the U.S.
24 Apr 2024 //
FDA
Novugen`s Generic Sunitinib Malate Receives Approval in the U.S.
21 Aug 2023 //
FDA